Related references
Note: Only part of the references are listed.Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma
Richard T. Maziarz et al.
LEUKEMIA & LYMPHOMA (2018)
Follicular lymphomas and their transformation: Past and current research
Miriam Mendez et al.
EXPERT REVIEW OF HEMATOLOGY (2017)
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
T. Terwilliger et al.
BLOOD CANCER JOURNAL (2017)
Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in Belgium
Johan Maertens et al.
ACTA CLINICA BELGICA (2017)
Characteristics and external validity of the German Health Risk Institute (HRI) Database
Frank Andersohn et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Healthcare burden and reimbursement of hospitalization during chemotherapy for adults with Ph-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia in France: a retrospective chart review
Herve Dombret et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
STandardized Reporting Of Secondary data Analyses (STROSA) - A recommendation
Enno Swart et al.
ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN (2014)
Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large National Private Claims Database
N. S. Majhail et al.
BONE MARROW TRANSPLANTATION (2013)
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
Adele K. Fielding et al.
BLOOD (2007)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
